Imidazopyridazines as modulators of IL-17

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11702422
APP PUB NO 20230081548A1
SERIAL NO

17576535

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present application discloses compounds having the following formula:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN PHARMACEUTICA NVBEERSE

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Behenna, Douglas San Juan Capistrano, US 3 4
Goldberg, Steven San Diego, US 36 260
Keith, John San Diego, US 65 173
Martin, Connor San Diego, US 6 4
McCarver, Stefan San Diego, US 13 8
Meduna, Steven P San Diego, US 43 159
Rhorer, Timothy B San Diego, US 6 2
Valdes, Alexander San Diego, US 3 4
Xue, Xiaohua San Diego, US 36 158

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 18, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 18, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00